Provided by Tiger Fintech (Singapore) Pte. Ltd.

Repligen

120.11
+1.261.06%
Post-market: 120.110.00000.00%16:54 EDT
Volume:854.50K
Turnover:101.46M
Market Cap:6.75B
PE:-286.72
High:120.28
Open:119.00
Low:115.86
Close:118.85
Loading ...

BRIEF-Repligen Q1 Adjusted EPS USD 0.39 Vs. IBES Estimate USD 0.35

Reuters
·
29 Apr

Repligen Outlook FY Adjusted EPS USD 1.63-1.72

THOMSON REUTERS
·
29 Apr

Repligen Corp: Reiterates 2025 Full Year Organic Revenue Guidance of 9.5% - 13.5%

THOMSON REUTERS
·
29 Apr

Repligen Q1 Adjusted Net Income USD 22 Million VS. Ibes Estimate USD 19.6 Million

THOMSON REUTERS
·
29 Apr

Repligen (RGEN) Q1 Earnings: What To Expect

StockStory
·
28 Apr

Analysts Offer Insights on Healthcare Companies: Bristol-Myers Squibb (BMY), Ironwood Pharma (IRWD) and Repligen (RGEN)

TIPRANKS
·
25 Apr

Will Repligen (RGEN) Beat Estimates Again in Its Next Earnings Report?

Zacks
·
24 Apr

Repligen (RGEN) Reports Next Week: Wall Street Expects Earnings Growth

Zacks
·
22 Apr

Three Stocks That May Be Undervalued In April 2025

Simply Wall St.
·
17 Apr

Repligen Corp : Leerink Partners Cuts Target Price to $180 From $200

THOMSON REUTERS
·
17 Apr

Repligen Corp : Canaccord Genuity Cuts Target Price to $150 From $170

THOMSON REUTERS
·
17 Apr

Repligen Is Maintained at Hold by Canaccord Genuity

Dow Jones
·
17 Apr

Repligen price target lowered to $150 from $170 at Canaccord

TIPRANKS
·
17 Apr

Repligen to Report First Quarter 2025 Financial Results

GlobeNewswire
·
15 Apr

Repligen (RGEN) Gets a Hold from Guggenheim

TIPRANKS
·
09 Apr

Repligen Appoints Jacob Johnson as Vice President Investor Relations

THOMSON REUTERS
·
08 Apr

Press Release: Repligen Appoints Jacob Johnson As Vice President Investor Relations

Dow Jones
·
08 Apr

RBC Cuts Price Target on Repligen to $202 From $219, Keeps Outperform Rating

MT Newswires Live
·
08 Apr

Repligen (RGEN) Moves 3.7% Higher: Will This Strength Last?

Zacks
·
08 Apr

Repligen Director Makes a Multi-Million Dollar Stock Move!

TIPRANKS
·
20 Mar